Up-regulation of P-glycoprotein expression by catalase via JNK activation in HepG2 cells

Redox Report

Volumn 11, Issue 4, 2006, Pages 173-178

  Li, Lin ^a   Xu, Jianfeng ^a   Min, Taishan ^a   Huang, Weida ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Catalase; JNK; MDR1; NAC; P glycoprotein; Reactive oxygen species (ROS)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; BETA ACTIN; CATALASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ACETYLCYSTEINE; ANTHRACENES; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; P-GLYCOPROTEIN; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINES; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 33749035710     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X116682     Document Type: Article

References (25)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
2. Simon SM, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994; 91: 3497-3504.
3. Volm M. Multidrug resistance and its reversal. Anticancer Res 1998; 18: 2905-2917.
4. Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 2000; 3: 268-280.
5. Ziemann C, Berkle A, Kahl GF, Hirsch-Ernst KI. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 1999; 20: 407-414.
6. Felix RA, Barrand MA. P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J Neurochem 2002; 80: 64-72.
7. Liu YW, Sakaeda T, Takara K et al. Effects of reactive oxygen species on cell proliferation and death in HeLa cells and its MDR1-overexpressing derivative cell line. Biol Pharm Bull 2003; 26: 278-281.
8. Davis RJ. Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 1999; 64: 1-12.
9. Tibbles LA, Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci 1999; 55: 1230-1254.
10. Denman AM. Molecular cloning: a laboratory manual [Book]. Immunology 1983; 49: 411.
11. Twentyman PR, Rhodes T, Rayner S. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J Cancer 1994; 30A: 1360-1369.
12. Joenje K Gille JJ, Oostra AB, Van der Valk P. Some characteristics of hyperoxia-adapted HeLa cells. A tissue culture model for cellular oxygen tolerance. Lab Invest 1995; 52: 420-428.
13. 2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. Free Radic Res 1994; 21: 317-327.
14. Benfey BG. Free radicals in biology and medicine [Book]. Am Sci 1986; 74: 674.
15. Clement MV, Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic Res 1999; 30: 247-252.
16. Liu R, Li B, Qiu M. Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-alpha. Oncogene 2001; 20: 1486-1496.
17. Petraccia L, Onori P, Sferra R et al. MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications. Clin Ter 2003; 154: 325-335.
18. Xiao E, Hu G, Liu P et al. The effect of different interventional treatments, on P-glycoprotein in different histopathological types and grades of primary hepatocellular carcinoma. J Tongji Med Univ 2000; 20: 231-234.
19. Nishikawa M, Tamada A, Hyoudou K et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004; 21: 213-221.
20. Miao ZH, Ding J. Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 2003; 63: 4527-4532.
21. 2-terminal kinase. Cancer Res 2006; 66: 445-452.
22. 2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J Biol Chem 1996; 271: 30950-30955.
23. Ledoux S, Yang R, Friedlander G, Laouari D. Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response. Cancer Res 2003; 63: 7284-7290.
24. 2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res 2004; 64: 9057-9061.
25. Bezombes C, Maestre N, Laurent G et al. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J 1998; 2: 101-109.